COCRYSTAL PHARMA NEW O.N. Net Asset Quality Index
COCRYSTAL PHARMA NEW O.N. net asset quality index. COCRYSTAL PHARMA NEW O.N. (8CC) has a Net Asset Quality Index of 65.2% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €9.71 Million minus total liabilities of €3.38 Million yields net assets of €6.33 Million. A higher index indicates a stronger, lower-leverage balance sheet. See COCRYSTAL PHARMA NEW O.N. (8CC) net assets for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of COCRYSTAL PHARMA NEW O.N. (2021–2025)
Net asset quality index of COCRYSTAL PHARMA NEW O.N. from 2021 to 2025. This chart shows how COCRYSTAL PHARMA NEW O.N.'s Net Asset Quality Index has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the index stands at 65.2%, representing net assets of €6.33 Million against total assets of €9.71 Million EUR. Check COCRYSTAL PHARMA NEW O.N. tangible book value ratio to evaluate the tangible quality of the company's equity base.
COCRYSTAL PHARMA NEW O.N. Net Asset Quality Index by Year (2021–2025)
COCRYSTAL PHARMA NEW O.N. net asset quality index by year from 2021 to 2025. The table below presents the year-by-year Net Asset Quality Index for COCRYSTAL PHARMA NEW O.N. from 2021 to 2025, covering 5 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 8CC market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 65.2% | €6.33 Million | €9.71 Million | €3.38 Million | ▼ -5.6 pp |
| 2024 | 70.8% | €9.52 Million | €13.46 Million | €3.93 Million | ▼ -13.6 pp |
| 2023 | 84.4% | €26.38 Million | €31.26 Million | €4.88 Million | ▼ -12.5 pp |
| 2022 | 96.9% | €39.57 Million | €40.84 Million | €1.27 Million | ▼ -0.8 pp |
| 2021 | 97.7% | €77.55 Million | €79.39 Million | €1.84 Million | — |